As Japan's most comprehensive bioindustry organization, JBA brings together a diverse membership including pharmaceuticals, healthcare, cosmetics, food and beverage, IT, chemicals, and energy. JBA also serves as Japan's representative in the International Council of Biotechnology Associations (ICBA). JBA plays a central role in fostering open innovation--bridging industry and academia, as well as domestic and international stakeholders in the biotechnology sector.
JBA actively engages in policy advocacy and maintains ongoing dialogue with policymakers in Japan. It has been a key contributor to the development of the "Bioeconomy Strategy" by the Japanese government. To support its members, JBA organizes internal study groups and seminars focused on biotechnology regulations, the latest scientific and technological developments, and opportunities for business collaboration. One of JBA's flagship programs is BioJapan, one of the world's largest and most influential biotechnology events. BioJapan has now become one of the three major global biotech events, alongside the BIO International Convention in the U.S. and BIO-Europe.
